We are live on ! Find out more
AIM

AIM ImmunoTech
AIM

35 hedge funds and large institutions have $15.5M invested in AIM ImmunoTech in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 5

0% more funds holding

Funds holding: 35 → 35 (0)

0% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 9

8% less capital invested

Capital invested by funds: $16.8M → $15.5M (-$1.36M)

Holders
35
Holders Change
–
Holders Change %
0%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
8
Reduced
5
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$344K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$298K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$143K
4
WG
Winton Group
United Kingdom
+$118K
5
RJFSA
Raymond James Financial Services Advisors
Florida
+$103K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$699K
2
BlackRock
BlackRock
New York
-$335K
3
Citadel Advisors
Citadel Advisors
Florida
-$234K
4
GCP
GSA Capital Partners
United Kingdom
-$170K
5
VF
Virtu Financial
New York
-$67K
Name Holding Trade Value Shares
Change 		Change in
Stake
LDFR
26
Lehman & Derafelo Financial Resources
Pennsylvania
$24K – – –
TCM
27
Traynor Capital Management
Pennsylvania
$24K – – –
Wells Fargo
28
Wells Fargo
California
$23K +$15K +70 +184%
SFG
29
SNS Financial Group
Minnesota
$22K +$21.4K +100 New
TRCT
30
Tower Research Capital (TRC)
New York
$21K +$20.8K +97 New
JP Morgan Chase
31
JP Morgan Chase
New York
$5K +$5.14K +24 New
Osaic Holdings
32
Osaic Holdings
Arizona
$2K +$857 +4 +80%
CFGS
33
Concourse Financial Group Securities
Alabama
$1K +$1.07K +5 New
APA
34
American Portfolios Advisors
New York
$490 – – –
Citadel Advisors
35
Citadel Advisors
Florida
– -$234K -1,034 Closed
GCP
36
GSA Capital Partners
United Kingdom
– -$170K -749 Closed
VF
37
Virtu Financial
New York
– -$67K -295 Closed
EGM
38
Engineers Gate Manager
New York
– -$41K -179 Closed
SFI
39
Susquehanna Fundamental Investments
Pennsylvania
– -$39K -170 Closed
Bank of Montreal
40
Bank of Montreal
Ontario, Canada
– -$11K -50 Closed
SPIA
41
Steward Partners Investment Advisory
New York
– -$11.3K -50 Closed
GWMIA
42
Global Wealth Management Investment Advisory
Florida
– -$1K -6 Closed
1
2

AIM Hedge Fund Activity: Q2 2021 in Review

35 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q2 2021, worth a combined $15.5M — down 8.1% from $16.8M a quarter earlier.

Fund positioning in AIM was balanced in Q2 2021: 9 funds opened new positions, 9 closed out, 8 added to existing stakes and 5 trimmed.

The largest buyer was State Street, opening a new position worth an estimated $344K. The largest seller was Renaissance Technologies, cutting an estimated $699K.

  • 35 institutional investors held AIM ImmunoTech (AIM) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $15.5M of AIM ImmunoTech stock for Q2 2021, down 8.1% quarter-over-quarter.
  • 9 funds opened new AIM ImmunoTech positions in Q2 2021 and 9 closed out, a net change of 0 holders.
  • The largest AIM ImmunoTech buyer in Q2 2021 was State Street, an estimated $344K added.
  • The largest AIM ImmunoTech seller in Q2 2021 was Renaissance Technologies, an estimated $699K sold.

Based on aggregated 13F filings for Q2 2021.